Medicine information
Uses & overview
ORAVERSE M is a combination tablet from Steris Healthcare containing Myo-Inositol IP 600 mg and Metformin Hydrochloride 500 mg. It combines an ingredient involved in cellular signalling with a medicine used to improve blood glucose regulation. Metformin is a biguanide medicine that helps lower blood glucose levels by reducing glucose production in the liver and improving the body's response to insulin. Myo-Inositol participates in cellular signalling pathways associated with several physiological processes, including insulin-related signalling. Key Product Features Brand Name: ORAVERSE M Composition: Myo-Inositol IP 600 mg + Metformin Hydrochloride 500 mg Company Name: Steris Healthcare Dosage Form: Tablets Therapeutic Category: Biguanide antidiabetic combination Primary Use: For appropriate clinical indications as determined by a healthcare professional Uses of ORAVERSE M Tablets Metformin is commonly prescribed to help manage type 2 diabetes mellitus. Depending on the patient's clinical condition and applicable prescribing guidance, metformin may also be considered in selected cases involving insulin resistance or polycystic ovary syndrome (PCOS). Myo-Inositol is included in some nutritional formulations intended to support metabolic and reproductive health. However, evidence for the benefits of myo-inositol varies by condition, and its inclusion does not establish that this combination treats PCOS or infertility. The suitability of ORAVERSE M depends on the patient's diagnosis, kidney function, blood glucose status, other medicines, and treatment objectives. It should not be used for self-treatment or as a substitute for an appropriate medical assessment. How the Ingredients Work Myo-Inositol IP 600 mg: Myo-inositol participates in cellular signalling pathways, including pathways associated with insulin action. Metformin Hydrochloride 500 mg: Metformin helps regulate blood glucose by reducing hepatic glucose production and improving insulin sensitivity. It does not usually cause low blood glucose when used alone, although the risk may increase when it is combined with certain other diabetes medicines. Important Safety Information Take ORAVERSE M only as prescribed by your healthcare professional. Metformin may cause gastrointestinal side effects, including nausea, diarrhoea, abdominal discomfort, and reduced appetite. Long-term use may be associated with low vitamin B12 levels. Metformin is not suitable for everyone and requires particular care in people with kidney impairment. Rarely, it can cause a serious condition called lactic acidosis, especially in certain high-risk circumstances. Inform your doctor if you have kidney or liver disease, severe infection, dehydration, or a planned procedure involving iodinated contrast. Your doctor may need to assess whether treatment should be temporarily interrupted.
How to use
Take ORAVERSE M Tablets exactly as prescribed by your healthcare professional. Follow the recommended dosage, timing, and duration stated on the approved product label. Metformin is often taken with meals to help reduce gastrointestinal side effects, but you should follow the instructions provided for your specific formulation. Do not crush or split the tablet unless the product information permits it. Do not change the dose without medical advice, and attend recommended blood glucose and kidney function assessments.
Storage
Store ORAVERSE M Tablets according to the storage instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat and moisture. Keep the medicine out of the reach of children. Do not use the tablets after the expiry date or if the packaging is damaged.
